Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;22(1):65-89.
doi: 10.1007/s10741-016-9591-2.

Genomic and rapid effects of aldosterone: what we know and do not know thus far

Milla Marques Hermidorff  1 , Leonardo Vinícius Monteiro de Assis  2 , Mauro César Isoldi  3
Affiliations
Review

Genomic and rapid effects of aldosterone: what we know and do not know thus far

Milla Marques Hermidorff et al. Heart Fail Rev. 2017 Jan.

Abstract

Aldosterone is the most known mineralocorticoid hormone synthesized by the adrenal cortex. The genomic pathway displayed by aldosterone is attributed to the mineralocorticoid receptor (MR) signaling. Even though the rapid effects displayed by aldosterone are long known, our knowledge regarding the receptor responsible for such event is still poor. It is intense that the debate whether the MR or another receptor-the "unknown receptor"-is the receptor responsible for the rapid effects of aldosterone. Recently, G protein-coupled estrogen receptor-1 (GPER-1) was elegantly shown to mediate some aldosterone-induced rapid effects in several tissues, a fact that strongly places GPER-1 as the unknown receptor. It has also been suggested that angiotensin receptor type 1 (AT1) also participates in the aldosterone-induced rapid effects. Despite this open question, the relevance of the beneficial effects of aldosterone is clear in the kidneys, colon, and CNS as aldosterone controls the important water reabsorption process; on the other hand, detrimental effects displayed by aldosterone have been reported in the cardiovascular system and in the kidneys. In this line, the MR antagonists are well-known drugs that display beneficial effects in patients with heart failure and hypertension; it has been proposed that MR antagonists could also play an important role in vascular disease, obesity, obesity-related hypertension, and metabolic syndrome. Taken altogether, our goal here was to (1) bring a historical perspective of both genomic and rapid effects of aldosterone in several tissues, and the receptors and signaling pathways involved in such processes; and (2) critically address the controversial points within the literature as regarding which receptor participates in the rapid pathway display by aldosterone.

Keywords: Aldosterone; G protein-coupled estrogen receptor-1 (GPER-1); Genomic effects; Mineralocorticoid receptor (MR); Rapid or non-genomic effect.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Endocrinology. 2001 Jun;142(6):2686-94 - PubMed
    1. Mol Cell Endocrinol. 2012 May 15;355(1):162-8 - PubMed
    1. Hypertension. 2005 Dec;46(6):1227-35 - PubMed
    1. J Comp Neurol. 2006 Jan 20;494(3):515-27 - PubMed
    1. Biochim Biophys Acta. 2013 Oct;1833(10):2143-52 - PubMed

MeSH terms

LinkOut - more resources